샘플 요청 목록

 카트 문의
시장보고서
상품코드
1559467

세계의 파면 분석기 - 시장 인사이트, 경쟁 구도, 시장 예측(-2030년)

Wavefront Aberrometer - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 파면 분석기 시장 규모는 예측 기간 동안 복합 연간 성장률(CAGR) 6.13%의 성장이 예상됩니다. 파면 분석기 수요는 주로 원시, 근시, 난시 등 안질환의 이환율 증가, 눈건강을 개선하는 정부의 이니셔티브 증가 등에 의해 세계적으로 뒷받침되고 있으며, 이들이 예측 기간 동안 시장의 성장을 가속하는 주요 요인이 되고 있습니다.

파면 분석기 시장 역학

Vision Center(2024년)에 따르면 현재 한국, 대만, 중국 등의 나라에서는 10대 후반의 젊은이들이 평균 84%-97%의 근시 유병률에 시달리고 있습니다. 세계 전체에서는 약 2억 2,400만 명(인구의 3% 가까이)이 강도 근시에 시달리고 있습니다. 2050년의 예측은 더욱 우려되어야 하며, 세계 인구의 거의 절반, 50억명이 근시가 될 것으로 예측되고 있습니다. 강도 근시의 유병률은 2050년까지 세계 인구의 거의 10%로 상승하여 약 10억 명이 영구적인 시력 장애의 위험에 노출될 것으로 예측됩니다. 세계의 근시 동향은 수백만 명의 사람들에게 영향을 미치고 있으며 도시화와 디지털화 동향으로 인해 증가하는 경향이 있습니다. 이 증가로 연구자와 의료 종사자는 이 문제의 원인, 영향, 솔루션을 탐구하고 있습니다. 근시가 되는 사람이 늘어남에 따라, 근시를 진단하기 위한 정기적인 안과 검진의 필요성이 높아지고 있습니다. 파면 분석기는 이러한 검사에 필수적인 도구이며 근시와 같은 굴절 이상을 정확하게 평가할 수 있습니다.

또한 눈 건강 증진을 목적으로 한 정부의 이니셔티브와 안과 기술의 진보가 시장 성장을 가속하고 있습니다. 예를 들어 2022년 8월, The International Agency for the Prevention of Blindness(IAPB)는 시력저하의 치료를 받지 않는 세계의 약 10억 명을 향해 안과 치료의 중요성을 명시하는 세계의 계발 캠페인을 개시 했습니다. 눈 건강을 유지하기 위한 정기적인 안과 검진의 중요성에 대한 인식이 높아짐에 따라 안과 검진을 받는 사람의 수도 증가할 전망입니다. 이러한 안과 검진 수요 증가는 결과적으로 파면 분석기 수요 증가로 이어집니다. 파면 분석기는 안과 전문가가 이러한 검사 중에 굴절 이상 및 기타 눈의 상태를 평가하는 데 사용하는 필수 도구입니다.

게다가 세계보건기구(2021년)는 2015년-2050년에 60세 이상의 인구가 12%에서 22%로 두배로 늘어나고, 최종적으로는 2050년까지 세계 전체에서 21억명에 달한다고 말합니다. 또한 2030년까지 6명 중 1명이 60세 이상이 된다고 합니다. 노화에 따라 노안이 될 가능성이 높아집니다. 파면 분석기는 노안을 포함한 굴절 이상을 상세하고 정확하게 측정 할 수 있기 때문에 안과 진료에서 점점 더 필수적입니다. 그 결과, 노화에 따른 시력 장애를 관리하기 위한 정확하고 효과적인 진단 도구에 대한 수요는 향후 수년간 증가할 것으로 예상됩니다.

따라서 근시 증가, 눈 건강 증진을 위한 정부의 이니셔티브, 노안이 되기 쉬운 노년 인구 증가 등 위의 모든 요인이 얽혀 소정의 예측 기간에 파면 분석기 시장을 견인할 것으로 전망 됩니다.

그러나 파면 분석기의 사용에 따른 측정치의 일관성과 원격검안을 동반한 원격의료의 진보는 최종 사용자층을 제한하는 잠재적인 요인이며, 예측기간의 파면 분석기 시장 성장을 억제합니다.

파면 분석기 시장의 부문 분석

파면 분석기 시장의 적응증 부문에서 원시 카테고리는 2023년 파면 분석기 시장에서 큰 수익 점유율을 차지할 것으로 추정됩니다. 향후 몇 년간, 이것은 예측 기간에 있어서 원시와 관련된 환자 인구의 많음, 원시와 관련된 파면 분석기의 장점 등에 기인할 것으로 예상됩니다.

National Institute of Health(2023년)에 따르면 현재 원시 유병률은 전 세계 6세에서 8.4%, 9-14세에서 2-3%, 15세에서 약 1%입니다. 파면 분석기는 이러한 모든 연령대의 원시 진단 및 관리에 매우 중요합니다.

이 보고서는 세계 파면 분석기 시장에 대한 조사 분석을 통해 각 지역 시장 규모와 예측, 지난 3년간의 제품/기술 개발, 각 부문의 성과 및 전망 등의 정보를 제공합니다.

목차

제1장 파면 분석기 시장 보고서 소개

제2장 파면 분석기 시장의 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 파면 분석기 시장의 주요 요인 분석

  • 파면 분석기 시장 성장 촉진요인
  • 파면 분석기 시장 성장 억제요인과 과제
  • 파면 분석기 시장의 기회

제6장 파면 분석기 시장의 Porter's Five Forces 분석

제7장 파면 분석기 시장 평가

  • 적응증
    • 원시
    • 근시
    • 난시
    • 기타
  • 최종 사용자별
    • 병원
    • 전문 클리닉
    • 외래 수술을 실시하는 진료소
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 파면 분석기 시장의 기업과 제품 프로파일

  • Carl Zeiss Vision GmbH
  • Alcon Inc
  • Johnson & Johnson Services, Inc
  • NIDEK CO.LTD
  • Essilor Instruments USA
  • CSOITALIA.I
  • Ziemer Ophthalmic Systems AG
  • Marco
  • Bausch & Lomb, Inc.
  • Tracey Technologies
  • Wavefront Dynamics

제9장 KOL의 견해

제10장 프로젝트 접근법

제11장 DelveInsight 정보

제12장 면책사항 및 문의

BJH 24.09.30

Wavefront Aberrometer Market By Indication (Hypermetropia, Myopia, Astigmatism, And Others), End-User (Hospitals, Speciality Clinics, Ambulatory Surgical Clinics, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to increasing incidence of eye disorders, increasing government initiatives to improve eye health, among others globally

The wavefront aberrometer market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The demand for wavefront aberrometers is primarily being boosted by the increasing incidence of eye disorders such as hypermetropia, myopia, and astigmatism, increasing government initiatives to improve eye health, among others globally, serving as key factors driving the growth of the wavefront aberrometer market during the forecast period from 2024 to 2030.

Wavefront Aberrometer Market Dynamics:

According to Vision Center (2024), currently, late teenagers and young adults in countries like Korea, Taiwan, and China suffer myopia prevalence rates ranging from 84% to 97% on average. Globally, approximately 224 million individuals, constituting nearly 3% of the population, suffer from severe myopia. The projections for 2050 are more alarming, with almost half of the world's population, constituting 5 billion people expected to be myopic. The prevalence of high myopia is anticipated to elevate for almost 10% of the global population by 2050, translating to around 1 billion individuals at a risk of permanent vision impairment. The global condition of myopia, or nearsightedness, is affecting millions and is on the rise due to trends in urbanization and digitalization. This increase has led researchers and healthcare professionals to explore the causes, effects, and solutions to this issue. As more people become myopic, there will be a greater need for regular eye exams to diagnose the condition. Wavefront aberrometers form a vital tool in these examinations, allowing for precise assessment of refractive errors like myopia.

Furthermore, government initiatives aimed at enhancing eye health, coupled with advancements in ophthalmology technology, are driving the market growth. For instance, in August 2022, The International Agency for the Prevention of Blindness (IAPB), launched a global awareness campaign by emphasizing the importance of eye care, for approximately 1 billion people worldwide lacking access to treatment for poor vision. As awareness grows about the importance of regular eye exams in maintaining eye health, there will be an increase in the number of individuals seeking eye care services. This rise in demand for eye examinations will consequently lead to an increased demand for wavefront aberrometers, which are essential tools used by eye care professionals to assess refractive errors and other eye conditions during these exams.

Moreover, the World Health Organization (2021) further stated that between 2015 to 2050, people above 60 years of age will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above. As people age, they are more likely to develop presbyopia. Wavefront aberrometers provide detailed and accurate measurements of refractive errors, including presbyopia, making them increasingly vital in ophthalmic practices. Consequently, the demand for precise and effective diagnostic tools to manage age-related vision impairments will rise in the upcoming years.

Hence, the interplay of all the factors mentioned above such as the increasing numbers of myopia, government initiatives for enhancing eye health, and the rising geriatric population being more prone to presbyopia are expected to drive the market for wavefront aberrometers during the given forecast period.

However, inconsistent readings associated with the use of wavefront aberrometers and advancements in telemedicine with remote eye examinations, are potential factors that will limit their end-user base, thus restricting the growth of the wavefront aberrometer market during the forecast period.

Wavefront Aberrometer Market Segment Analysis:

Wavefront Aberrometer market by Indication (Hypermetropia, Myopia, Astigmatism, and Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of The World)

In the indication segment of the wavefront aberrometer market, the hypermetropia category is estimated to have a significant revenue share in the wavefront aberrometer market in 2023. In the upcoming years, this can be attributed to the large patient population associated with hypermetropia, the advantages of wavefront aberrometers concerning hypermetropia, among others during the forecast period.

According to the National Institute of Health (2023), currently, the prevalence of hypermetropia ranges from 8.4% at age six, 2-3% from nine to fourteen years, and approximately 1% at fifteen years across the globe. Wavefront aberrometers are crucial in diagnosing and managing hypermetropia across all these age groups.

These devices offer detailed and precise measurements of refractive errors, enabling the accurate detection of hypermetropia. By capturing and analyzing light waves through the eye, wavefront aberrometers can determine the extent of hypermetropia and identify associated higher-order aberrations. This precision is crucial for developing customized corrective measures, such as prescription glasses or contact lenses, particularly in children and adolescents. Early detection and intervention can prevent the progression of vision problems, making wavefront aberrometers invaluable tools in eye care practices for effectively managing hypermetropia and enhancing overall eye health. Furthermore, these devices capture comprehensive optical data, allowing for the development of personalized corrective measures such as customized lenses or surgical plans.

Therefore, the various advantages and applications provided by these devicesin hypermetropia treatment are expected to drive the overall growth of the wavefront aberrometer market during the forecast period.

North America Is Expected To Dominate The Overall Wavefront Aberrometer Market:

North America is expected to account for the highest proportion of the wavefront aberrometer market in 2023, out of all regions. This is because of the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed and sophisticated healthcare infrastructure, among others being factors that drive the expansion of the wavefront aberrometer market in North America.

According to the American Academy of Ophthalmology (2024), 33% of people in the U.S. have astigmatism. Astigmatism affects people of all ages and races. Babies may even have astigmatism, although most soon outgrow it. Additionally, it stated that 14 million Americans aged 40 and above are affected with hypermetropia. Since these tools are essential in the diagnosis and management of astigmatism and hypermetropia, these devices analyze the path of light waves through the eye, enabling the detection of even subtle vision imperfections related to these conditions. This high level of precision is crucial for tailoring corrective measures, such as prescription glasses, contact lenses, or refractive surgeries, to each individual's unique needs. With the prevalence of astigmatism and hypermetropia continuously rising due to changing demographics and lifestyle habits, the demand for wavefront aberrometers is expected to grow substantially. Thus, these devices play a vital role in providing effective solutions for improving vision and enhancing overall eye health.

According to statistics unveiled by the Canadian Council of the Blind in February 2022, approximately 1.2 million Canadians suffered vision loss in 2020. Projections for the year 2030 estimate that this figure will surge to 1.58 million. Such increase in the number of cases of vision impairment are anticipated to fuel the uptake of visual impairment devices, consequently influencing market dynamics in the region. As awareness of eye health grows in response to the rising prevalence of vision loss, there may be a greater emphasis on preventive care and early detection of eye conditions. Eye care professionals may rely on wavefront aberrometers more frequently to accurately diagnose and manage refractive errors. The increasing prevalence of vision impairment is expected to impact the market for wavefront aberrometers by driving the demand for comprehensive eye care services and diagnostic tools.

Therefore, the interplay of all the above-mentioned factors will lead to an increase in the North American wavefront aberrometer market growth during the forecast period from 2024 to 2030.

Wavefront Aberrometer Market Key Players:

Some of the key market players operating in the Wavefront Aberrometer market include Carl Zeiss Vision GmbH, Alcon Inc, Johnson & Johnson Services, Inc, NIDEK CO.LTD, Essilor Instruments USA, CSOITALIA.I, Ziemer Ophthalmic Systems AG, Marco, Bausch & Lomb, Inc., Tracey Technologies, Wavefront Dynamics, and others.

Recent Developmental Activities In The Wavefront Aberrometer Market:

  • In March 2023, WaveFront Dynamics Inc., an ophthalmic medical device company, announced the commercial launch of its aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer captures a video of the eye's dynamic optical system over time.

Key Takeaways From The Wavefront Aberrometer Market Report Study

  • Market size analysis for current Wavefront Aberrometer market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the Wavefront Aberrometer market.
  • Various opportunities available for the other competitors in the Wavefront Aberrometer market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Wavefront Aberrometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Wavefront Aberrometer market growth in the coming future?

Target Audience Who Can Be Benefited From This Wavefront Aberrometer Market Report Study

  • Wavefront aberrometer product providers
  • Research organizations and consulting companies
  • Wavefront aberrometer - related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in wavefront aberrometer
  • Various end-users who want to know more about the wavefront aberrometer market and the latest technological developments in the wavefront aberrometer market.

Frequently Asked Questions For The Wavefront Aberrometer Market:

1. What are wavefront aberrometers?

Wavefront aberrometer is a diagnostic device used in ophthalmology to measure the wavefront aberrations of the eyes. These devices are particularly useful for assessing both common refractive errors and more complex optical aberrations.

2. What is the market for wavefront aberrometers?

The wavefront aberrometer market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the wavefront aberrometer market?

The demand for wavefront aberrometer is primarily being boosted by increasing incidence of eye disorders such as hypermetropia, myopia, and astigmatism, increasing government initiatives to improve eye health, and others globally serve as key factors driving the growth of the wavefront aberrometer market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the wavefront aberrometer market?

Some of the key market players operating in the Wavefront Aberrometer include Carl Zeiss Vision GmbH, Alcon Inc, Johnson & Johnson Services, Inc, NIDEK CO.LTD, Essilor Instruments USA, CSOITALIA.I, Ziemer Ophthalmic Systems AG, Marco, Bausch & Lomb, Inc., Tracey Technologies, Wavefront Dynamics, and others.

5. Which region has the highest share in the wavefront aberrometer market?

North America is expected to dominate the overall Wavefront Aberrometer market during the forecast period from 2024 to 2030. This is because of the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed and sophisticated healthcare infrastructure, among others being factors that drive the expansion of the wavefront aberrometer market in North America.

Table of Contents

1. Wavefront Aberrometer Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Wavefront Aberrometer Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Wavefront Aberrometer Market Key Factors Analysis

  • 5.1. Wavefront Aberrometer Market Drivers
    • 5.1.1. Increasing incidence of eye disorders
    • 5.1.2. Increasing Government initiatives to improve eye health
    • 5.1.3. Rising geriatric population
  • 5.2. Wavefront Aberrometer Market Restraints and Challenges
    • 5.2.1. Inconsistent readings associated with the use of wavefront aberrometer
    • 5.2.2. Advancements in telemedicine and remote eye examinations
  • 5.3. Wavefront Aberrometer Market Opportunities
    • 5.3.1. Wavefront-guided LASIK and other refractive surgeries

6. Wavefront Aberrometer Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Wavefront Aberrometer Market Assessment

  • 7.1. Indication
    • 7.1.1. Hypermetropia
    • 7.1.2. Myopia
    • 7.1.3. Astigmatism
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospital
    • 7.2.2. Speciality Clinics
    • 7.2.3. Ambulatory Surgical Clinics
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Wavefront Aberrometer Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Wavefront Aberrometer Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.3.3. India Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Wavefront Aberrometer Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Wavefront Aberrometer Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Wavefront Aberrometer Market Size in USD million (2021-2030)

8. Wavefront Aberrometer Market Company and Product Profiles

  • 8.1. Carl Zeiss Vision GmbH
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Alcon Inc
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Johnson & Johnson Services, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. NIDEK CO.LTD
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Essilor Instruments USA
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. CSOITALIA.I
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Ziemer Ophthalmic Systems AG
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Marco
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Bausch & Lomb, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Tracey Technologies
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Wavefront Dynamics
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제